Onkologie 2020: 14(Suppl.C): 30-34 | DOI: 10.36290/xon.2020.053

Cutaneous adverse effects of anticancer treatment

Miroslav Důra
Dermatovenerologická klinika 1. LF UK a VFN, Praha

The present article summarizes cutaneous adverse effects of anticancer treatment - chemotherapy, targeted therapy, and immunotherapy. Also discussed are cutaneous adverse effects of radiotherapy and the recall reactions. To evaluate severity, the new CTCAE v5.0 classification is taken into account; in the case of radiation radiation dermatitis dermatitis, the RTOG scale is used. Appropriate education, prevention, early recognition and treatment can all aid in fighting the inevitable adverse effects of anticancer treatment in an effective way.

Keywords: adverse effect, chemotherapy, targeted therapy, immunotherapy, radiotherapy, recall reaction.

Published: June 2, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Důra M. Cutaneous adverse effects of anticancer treatment. Onkologie. 2020;14(Suppl.C):30-34. doi: 10.36290/xon.2020.053.
Download citation

References

  1. Jedličková H, Vokurka S, Vojtíšek R, Malečková A. Alopecie a poškození vlasů indukované onkologickou terapií. Klin Onkol, 2019; 32(5): 353-359. Go to original source... Go to PubMed...
  2. Sibaud V, Delord JP, Robert C. Dermatologie des traitements anticancéreux: guide pratique. Toulouse: Éditions Privat, 2014: 231 s.
  3. Bhushan P, Manjul P, Baliyan V. Flagellate dermatoses. Indian J Dermatol Venereol Lepros. 2014 Mar-Apr; 80(2): 149-152. Go to original source... Go to PubMed...
  4. Cetkovská P, Pizinger K, Štork J. Kožní změny u interních onemocnění. Praha: Grada, 2010: 240 s.
  5. Robert C. Traitement du mélanome par inhibiteurs de BRAF: manifestations cutanées. Montrouge, France: John Libbey Eurotext. 2012: 45 s.
  6. Haanen JBAG, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, Jordan K, on behalf of the ESMO Guidelines Committee, Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 2017; 28(Suppl. 4): July 2017, Pages iv119-iv142. Go to original source...
  7. McPherson T, Exton LS, Biswas S, Creamer D, Dziewulski P, Newell L, Tabor KL, Wali GN, Walker G, Walker R, Walker S, Young AE, Mohd Mustapa MF, Murphy R. British Association of Dermatologists' guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018. Br J Dermatol. 2019 Jul; 181(1): 37-54. Go to original source...
  8. Žemličková M. Poradiační poškození kůže, prevence a léčba. Podpůrná léčba 2019: 5-8.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.